drugset / Trial / NCT05814952
Safety and Efficacy Study of LX103 Treatment of X-Linked Retinoschisis (XLRS)
Recruiting
12 enrolled
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Innostellar Biotherapeutics · collab
NaSingle-groupOpen-labelTreatment
Summary
The goal of this study is to evaluate the safety and efficacy of LX103 treatment of X-linked retinoschisis. This study will enroll subjects aged ≥ 6 years old to receive a single unilateral intravitreal (IVT) injection of LX103 to evaluate its safety and efficacy.
Timeline
- Start
- 2022-12-13
- Primary completion
- 2024-08
- Completion
- 2028-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LX103 | Unknown | 5e+10 vg | Intravitreal |
| Subject | LX103 | Unknown | 1e+11 vg | Intravitreal |